InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,954.75
(
1.69%
)
Post# of 1189
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

MikeCr

Send PM Follow Ignore
Followers 42
Posts 5506
Boards Moderated 0
Alias Born 01/28/2010

MikeCr

Re: JPetroInc post# 943

Friday, 06/30/2017 12:59:32 AM

Friday, June 30, 2017 12:59:32 AM

Post# of 1189
March 10, 2016 when SeeThruEquity coverage began, AVDX pps was 0.40
12 months later March 10, 2017 it was 0.23
NOW it's 0.077

So much for the 2.97 target price.

NEW YORK, NY / ACCESSWIRE / March 10, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage on Avant Diagnostics, Inc. (AVDX) with a price target of $2.97.

"We are initiating coverage with a 12-month price target of $2.97 per share."



https://finance.yahoo.com/news/seethruequity-initiates-coverage-avant-diagnostics-181400469.html

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up